What's new

Human medicines European public assessment report (EPAR): Alofisel, darvadstrocel, Date of authorisation: 23/03/2018, Revision: 12, Status: Withdrawn

Human medicines European public assessment report (EPAR): Alofisel, darvadstrocel, Date of authorisation: 23/03/2018, Revision: 12, Status: Withdrawn

Mar 26, 2025 - 12:17
 0
Human medicines European public assessment report (EPAR): Alofisel, darvadstrocel, Date of authorisation: 23/03/2018, Revision: 12, Status: Withdrawn
Human medicines European public assessment report (EPAR): Alofisel, darvadstrocel, Date of authorisation: 23/03/2018, Revision: 12, Status: Withdrawn
Read More

Tags:

Previous Article

AutoChat rebrands as Novaco AI to drive the future of virtual assistants

Next Article

Nectar360 and Dulux Decorator Centre celebrate 20-year partnership

Related Posts

Clinical Trials Information System (CTIS) bitesize talk: End of transition period and notifications including serious breach, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 October 2024, 15:30 (CEST) to 16 October 2024, 17:00 (CEST)

Clinical Trials Information System (CTIS) bitesize talk...

Mar 3, 2025  0

EMEA-002438-PIP02-19-M03

EMEA-002438-PIP02-19-M03

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Gencebok, caffeine citrate, Date of authorisation: 19/08/2020, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 12, 2025  0